Migraine, mental disorders have bidirectional relationship

Migraines have a two-way relationship with psychiatric disorders such as anxiety and depression, with one potentially increasing the risk of the other, researchers reported Cyreus.

“Psychiatric disorders associated with migraines include anxiety disorders, panic disorders, bipolar disorder, and depression.” Ayushi S. Dengare, MPH, When Darshna G. Hulmari Written by both Jawaharlal Nehru Medical College, Wardha, India. “It’s also estimated that people who suffer from migraines are about five times more likely to develop depression than people without migraines.”

According to Dhengare and Fulmali, migraine and psychiatric disorders such as depression, anxiety, mood swings, and bipolar disorder share the same clinical features, so the two are “closely related.” That’s it. People with migraine disorders are more prone to anxiety disorders than the general population.

“There is a two-way relationship between psychiatric disorders and migraine, with one condition increasing the risk of the other,” the authors wrote. There was a 67% chance of migraines in the anxiety clinic sample.”

The clinical features of migraine are observed as episodic headaches characterized by pain felt on one side of the head, the researchers write. more likely to experience anxiety and suicidal tendencies.

“Both migraine and depression show a two-way relationship, with one increasing the risk of developing the other. The directional association appears to be migraine-specific,” the authors wrote.

Migraine headaches can be stimulated by stress, lack of sleep, eating or fasting, high intensity light, noise, or smells, researchers report. but “responds well” to botulinum toxin or Botox (Allergan).

Both botulinum toxin A and botulinum toxin B have been shown to be effective, but botulinum toxin A (BoNT-A) is more widely used because it has the least noticeable and long-lasting side effects. writes the authors.

According to this study, BoNT-A has been used for the management of chronic migraine for over 15 years and has recently emerged as a safe alternative for preventing persistent migraine.

“Botulinum toxin is a neurotoxin produced by bacteria. Clostridium botulinumBotulinum toxin is commonly used in the form of injections.fine [tolerated] Side effects are few or relatively minimal,” the researchers wrote. “Not only does it help with migraines, but it is also beneficial in dealing with various involuntary muscle contraction disorders such as cervical dystonia, hemifacial spasm, and blepharospasm.”

The FDA approved botulinum toxin for use as a prophylactic treatment for chronic migraines in 2010.

“Recent advances in the treatment of migraine and related neuropathic pain with botulinum toxin have benefited many patients,” the authors wrote. has not been found and further research is needed.”